Irritable bowel syndrome (IBS) causes bouts of stomach cramps, diarrhea, bloating or constipation, where it is a common and long-term condition of the digestive systems. The symptoms of this syndrome vary according to individuals and can last from few days to a few months at a time. It is also observed during stress or after eating certain food. It is a gastrointestinal disorder of the gut that is characterized by colon muscle contractions that mainly affects the large intestine. It is mainly observed in elderly people.
It is diagnosed by performing blood tests and endoscopy. As this syndrome is not completely curable, the symptoms can be managed using medicines. Irritable bowel syndrome treatment market is underpenetrated and in the nascent stage. Various investigations are carried out to rule out conditions such as stool microscopy and culture to exclude infectious conditions, blood test like full blood examination, erythrocyte sedimentation, liver function tests and serological testing, abdominal ultrasound is carried out to rule out gallstones and other biliary tract diseases, endoscopy and biopsies to exclude inflammatory bowel disease and hydrogen breath testing to exclude fructose and lactose malabsorption.
By Disease Type
By End User
Rise in novel therapeutic classes fuels growth of the irritable bowel syndrome treatment market
As of 2016, there are only 2 medications approved by Food Drug Administration (FDA) for irritable bowel syndrome, namely Alosetron (Lotronex) and Lubiprostone (Amitiza) and both these medications are proved right only in women in the U.S. LINZESS is FDA approved to treat IBS with constipation in both men and women, while in Japan, Irribow drug (ramosetron) is available. Due lack of drugs with safety and efficacy there is weak competition between manufacturers. However, the market scenario is expected to change after the launch of new disease treatment medications. Rifaximin (Xifaxan) is an antibiotic approved in May 2015 by FDA in the U.S. for treatment of IBS with diarrhea in adults. According to International Foundation for Functional Gastrointestinal Disorders, Inc. (IFFGD) new prescription drugs are being studied currently but have not yet approved by FDA for treatment. Drugs for IBS with constipation are currently in third phase of clinical trials that include plecanatide, and elobixibat which is a first-in-class compound. These new drugs are expected to show rise in irritable bowel syndrome treatment market in the near future.
Asia Pacific to be Growth Engine of the Irritable Bowel Syndrome Treatment Market
Irritable bowel syndrome treatment is segmented geographically into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. New drugs with improved efficacy which provide relief to irritable bowel syndrome and increase in awareness regarding chronic nature of the syndrome favors the growth of irritable bowel syndrome treatment market in Asia-Pacific. Most of the drugs are approved only for the U.S., making it the key geographic region for irritable bowel market. Europe also favors the market due to rising incidence of irritable bowel syndrome in the region.
Key players operating in irritable bowel syndrome treatment market
Key players in irritable bowel syndrome treatment market include Sucampo Pharmaceuticals, Inc., Ironwood Pharmaceuticals, valeant Pharmaceuticals International Inc., Lexicon Pharmaceuticals, Abbott Laboratories, Salix Pharmaceuticals, Inc., Allergan Plc and GlaxoSmithKline plc.
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.[email protected]
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.